Key Considerations Around Underrepresented Populations In Clinical Trials

By Joan Busner, PhD., Bill Byrom, PhD., Greta Marie de Waal, PhD., and Lauren Crooks, MSc

When aiming for equitable healthcare outcomes in your research, including specific population groups and excluding others can negatively impact your research validity and generalizability. Addressing these disparities is essential to the current landscape of diversity and accessibility in clinical research. Explore key considerations for including underrepresented populations in clinical research, and regulatory guidance around the topic.